newsfilter
← Latest News
PR Newswire·

Medivir's MIV-818 obtains the International Nonproprietary Name fostroxacitabine bralpamide

STOCKHOLM, Jan. 18, 2022 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR-B) today announced that the World Health Organization (WHO) has selected the International Nonproprietary Name (INN) fostroxacitabine bralpamide as the official generic name for